A new drug in clinical trials is showing promise in lowering a key genetic risk factor for heart attacks and ...

Discover how cancer treatments impact heart health and learn strategies to mitigate cardiovascular risks during and after ...

A straightforward £5 blood test could accurately allow doctors to predict someone’s risk of heart attacks and strokes in the ...

Emergency text alerts, STEMI heart attack treatment evolution, and the race against time in cardiology procedures explained ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

A heart attack and broken heart syndrome share similar symptoms But the two are separate conditions requiring distinct ...

Did you know men and women's heart cells prefer different kinds of fuel? Gender differences are emerging as scientists turn ...

Heart disease is the leading cause of death among women, yet many miss the early warning signs due to subtle or atypical ...

The decision to move forward with a heart transplant is made when all other treatment options been unsuccessful.

A simple £5 blood test for the protein troponin could predict a person's risk of heart attacks and strokes with greater accuracy than ever before, research suggests.

Discover how the experimental drug lepodisiran dramatically lowers lipoprotein(a) levels, potentially transforming treatment ...